Modelling Seizure Rates Rather Than Time to an Event Within Clinical Trials of Antiepileptic Drugs

BMC Medical Research Methodology - United Kingdom
doi 10.1186/s12874-020-00965-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antiepileptogenesis and Seizure Prevention Trials With Antiepileptic Drugs: Meta-Analysis of Controlled Trials

Epilepsia
Neurology
2001English

Sample Size Formula for Joint Modelling of Longitudinal and Time-To-Event Data in Clinical Trials

Trials
MedicinePharmacology
2013English

Erratum to “Survival of the Fittest: Time-To-Event Modelling of Crystallisation of Amorphous Poorly Soluble Drugs”

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2016English

Application of Time-To-Event Methods in the Assessment of Safety in Clinical Trials

Chapman & Hall/CRC Biostatistics Series
2009English

Critical Design Considerations for Time-To-Event Endpoints in Amyotrophic Lateral Sclerosis Clinical Trials

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Dropout Rates in Placebo-Controlled and Active-Control Clinical Trials of Antipsychotic Drugs

Archives of General Psychiatry
2005English

Genomics Drugs in Clinical Trials

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2010English

Practice Parameter: A Guideline for Discontinuing Antiepileptic Drugs in Seizure-Free Patients--Summary Statement

Neurology
Neurology
1996English

Clinical Pharmacokinetic Interactions Between Antiepileptic Drugs and Hormonal Contraceptives

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy